The healthcare world is observing a significant shift in diabetes management with the emergence of GLP-1 transdermal devices. These patches offer a possibly more comfortable alternative to shots of GLP-1 receptor agonists, reducing the need for daily needle pokes. The technology delivers the medication directly through the surface, arguably improvi